GRANT SEAN (Chief Financial Officer) received a stock award from VERA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/20/2025ACC: 0001415889-25-004846
Officer· Chief Financial Officer
Since Jul 2021
+80.70K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
80.70K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+26.90K
Price / share
—
Trade value
—
% of position
40.6%
2/18/2025
66.34K→93.24K
Total
Net shares
+26.90K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/18/2025 | A · Award | +26.90K | — | — | 40.6% | 66.34K | 93.24K |
| Total | +26.90K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Class A Common Stock
53.80K shares
Shares
+53.80K
Strike price
29.18
Held after
53.80K
Exercisable
—
2/18/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Class A Common Stock53.80K shares | 2/18/2025 | A · Award | +53.80K | 29.18 | — | 53.80K |
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
IndirectShares owned5K
Total
5K indirect5K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 5K | Indirect |
| Total | 5K | 5K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported